Lumen
US$ 26.32
glp-1 market news november 2025 Receptor Agonist Size GLP-1 Receptor Agonists Obesity Drugs
Description
Bringing Zepbound single-dose vials to patients will help more people living with obesity manage this chronic condition
GLP-1-derived nonapeptide GLP-1(28-36) amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice
Hypoglycemia risk with tirzepatide monotherapy is low due to its glucose-dependent mechanism of action
And how do we reckon with their place in a culture that prioritizes thinness sometimes to the point of real danger to someones health
